Abstract
There is now considerable evidence that the clinical outcome in patients with acromegaly can be improved very substantially by means of better surgical expertise and effective medical therapies used in a flexible and innovative manner. Medical therapy alone in patients who have not undergone surgery or radiotherapy (primary medical therapy) offers the prospect of near normalisation of GH/IGF-I levels together with substantial tumour shrinkage in a significant number of patients.
Original language | English |
---|---|
Pages (from-to) | 387-99 |
Number of pages | 13 |
Journal | Clinical Endocrinology |
Volume | 58 |
Issue number | 4 |
Publication status | Published - 1 Apr 2003 |